Moderna insider plans $5.8M stock sale in 2026

Rhea-AI Filing Summary

Moderna, Inc. (MRNA) insider Stephen Hoge filed a Rule 144 notice planning to sell 40,294 shares of common stock, with an aggregate market value of $5,807,745.84, through Fidelity Brokerage Services LLC, with an expected sale date of September 14, 2026 on NASDAQ.

The planned sale is tied to a stock option exercise with cash payment to the issuer. Moderna reports 399,235,889 shares outstanding, which is a baseline figure, not the amount being sold. Hoge also sold 53,336 shares on June 15, 2026 for $2,739,870.32 and 53,336 shares on July 15, 2026 for $3,605,513.60.

Key Figures

Shares to be sold: 40,294 shares Aggregate market value of planned sale: $5,807,745.84 Shares outstanding: 399,235,889 shares +4 more

7 metrics

Shares to be sold 40,294 shares Planned Rule 144 sale by Stephen Hoge through Fidelity Brokerage Services LLC

Aggregate market value of planned sale $5,807,745.84 Value of 40,294 Moderna common shares to be sold

Shares outstanding 399,235,889 shares Moderna common stock outstanding, provided as context in the notice

Shares sold June 15, 2026 53,336 shares Sale of Moderna common stock by Stephen Hoge on June 15, 2026

Proceeds June 15, 2026 sale $2,739,870.32 Aggregate sale price for 53,336 shares on June 15, 2026

Shares sold July 15, 2026 53,336 shares Sale of Moderna common stock by Stephen Hoge on July 15, 2026

Proceeds July 15, 2026 sale $3,605,513.60 Aggregate sale price for 53,336 shares on July 15, 2026

Key Terms

Rule 144, stock option exercise, aggregate market value, Form 144

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock option exercise financial

"Common | 09/14/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common | Fidelity Brokerage Services LLC ... | 40294 | 5807745.84"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale did Moderna (MRNA) insider Stephen Hoge file under Form 144?

Stephen Hoge filed to sell 40,294 shares of Moderna common stock under Rule 144, with an aggregate market value of $5,807,745.84, expected to be sold on or about September 14, 2026 through Fidelity Brokerage Services LLC on NASDAQ.

How many Moderna (MRNA) shares has Stephen Hoge sold in the past three months?

Over the past three months, Stephen Hoge reported two sales of Moderna common stock: 53,336 shares on June 15, 2026 for $2,739,870.32 and 53,336 shares on July 15, 2026 for $3,605,513.60.

What is the nature of the planned Moderna (MRNA) share sale by Stephen Hoge?

The planned sale of 40,294 shares of Moderna common stock by Stephen Hoge is related to a stock option exercise, with the transaction described as a cash payment to the issuer and an anticipated sale date of September 14, 2026.

What aggregate market value is associated with Stephen Hoge’s planned Moderna (MRNA) sale?

The planned sale of 40,294 Moderna shares under Rule 144 has an aggregate market value of $5,807,745.84, based on the figures reported in the notice filed through Fidelity Brokerage Services LLC.

How many Moderna (MRNA) shares are reported outstanding in the Form 144 notice?

The notice reports 399,235,889 shares outstanding of Moderna common stock. This is given as a baseline outstanding share count and is separate from the 40,294 shares covered by the planned Rule 144 sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 02:40 PM Accepted by SEC EDGAR 09/14/2026 - 02:39 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001760669
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Moderna, Inc.
SEC File Number	001-38753
Address of Issuer	325 BINNEY STREET CAMBRIDGE MASSACHUSETTS 02142
Phone	6177146500
Name of Person for Whose Account the Securities are To Be Sold	Hoge Stephen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	40294	5807745.84	399235889	09/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/14/2026	Stock Option Exercise	Issuer			40294	09/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	06/15/2026	53336	2739870.32
Stephen Hoge 325 Binney Street Cambridge MA 02142	Common	07/15/2026	53336	3605513.60

144: Remarks and Signature

Remarks
Date of Notice	09/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Stephen Hoge
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)